Nanotech

NanoTech Pharma Inc. is a specialty pharmaceutical company focused on the development and commercialization of innovative drug delivery systems to enable precision nanomedicine. The company's core technology is built upon three pillar platforms: Liposomes, Lipid Nanoparticles (LNPs), and Nanocrystals, which are designed to navigate biological barriers and improve the therapeutic index of various drug modalities. Their proprietary AccuLNP platform utilizes a library of ionizable lipids for the efficient delivery of nucleic acids, including mRNA and siRNA. NanoTech Pharma targets a diverse range of therapeutic areas such as oncology, infectious diseases, mental health disorders, and chronic inflammation. By leveraging the 505(b)(2) regulatory pathway, the company aims to accelerate the development of improved formulations of established active pharmaceutical ingredients.